Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001641172-25-010985

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2025 · Mar 31, 2025 $397K
Cash And Equivalents Q1 2025 · Dec 31, 2024 $673.26K
Current Liabilities Q1 2025 · Mar 31, 2025 $9.83M
Current Liabilities Q1 2025 · Dec 31, 2024 $9.61M
Total Liabilities Q1 2025 · Mar 31, 2025 $9.86M
Total Liabilities Q1 2025 · Dec 31, 2024 $9.65M
Current Assets Q1 2025 · Mar 31, 2025 $452.71K
Current Assets Q1 2025 · Dec 31, 2024 $740.29K
Total Assets Q1 2025 · Dec 31, 2024 $1.51M
Shares Diluted Q1 2025 · Mar 31, 2024 1.04B sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$489.53K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$6.24M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$5.71M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Sga Expense Q1 2025 · Mar 31, 2024 $164.38K
Rd Expense Q1 2025 · Mar 31, 2024 $29.44K
Net Income Q1 2025 · Mar 31, 2024 −$507.88K
Operating Income Q1 2025 · Mar 31, 2024 −$448.71K